ruxolitinib

⇄

BCR activator of RhoGEF and GTPase ; Mus musculus







1 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 22875628 Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements. 2013 Mar 1